Indian Ceramics Asia soon to become industry’s No. 1 show
India Pharma 2019 & India Medical Device 2019 to be held in Bengaluru on 18-19 February ’19
03 January 2019, New Delhi : “Endevour of the Government is to provide affordable quality healthcare for all and boost indigenous pharma sector through ‘Make in India’. In this direction, Cabinet has given approval for 100 % FDI under automatic route for manufacturing of medical devices”, said Union Minister for Chemicals & Fertilizers and Statistics & Programme Implementation, D. V. Sadananda Gowda while addressing the media during the Curtain Raiser Press Conference for India Pharma 2019 & India Medical Device 2019, here today.
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Commerce & Industry (FICCI), is organising the 4th International Conference on Pharmaceutical & Medical Device sector on 18-19 February, 2019 in Bengaluru. The theme for India Pharma 2019 is ‘Enabling Quality Affordable Healthcare’ and that of India Medical Device 2019 is ‘Med-Tech India: Gearing up for Ayushman Bharat’.
D. V. Sadananda Gowda will inaugurate the two-day event, which is India’s biggest Global Conference on Pharma Industry and Medical Devices, and address the distinguished gathering in the presence of Minister of State for Chemicals & Fertilizers and Road Transport & Highways, Shipping, Mansukh L. Mandaviya.
During the Curtain Raiser, D. V. Sadananda Gowda said that the flagship event would bring key stakeholders of the pharma and medical devices sectors under one roof and provide an opportunity to discuss Government policy and challenges facing the Industry. Government is striving to make the processes in the sector as transparent and easy as possible, he added.
In the main event in Bengaluru, over 150 CEOs of the global pharma and medical device industry are expected to participate. International Drug Regulators from 15 countries have been invited to the event for interaction with Indian Drug Regulators and Industry Regulatory Officers. Ambassadors & Commercial Counsellors of more than 50 countries have been invited for close interaction with Government of India and participating Industry.
Thematic sessions will be held on areas of Artificial Intelligence in Pharma, Import Export issues, Biologicals, Biopharmaceuticals and New Chemical Entities (NCEs) for the Pharmaceutical Sector. For the Medical Devices Sector, thematic sessions will be held on Diagnostics Ecosystem, Ease of Doing Business and Health Technology Assessment (HTA) Framework. Technical workshop by World Health Organization will help in addressing key challenges before the industry and will also provide tremendous business linkages to the participating companies.